Q32 Bio
QTTB
106 hedge funds and large institutions have $262M invested in Q32 Bio in 2026 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 24 increasing their positions, 15 reducing their positions, and 15 closing their positions.
259% more capital inflows, than outflows
Capital inflows: $181M | Capital outflows: $50.4M
220% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 15
60% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 15
45% more funds holding
Funds holding: 73 → 106 (+33)
0% less call options, than puts
Call options by funds: $585K | Put options by funds: $587K
45.84% less ownership
Funds ownership: 151.68% → 105.84% (-46%)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$30.5M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$20.8M |
| 3 |
JP Morgan Chase
New York
|
+$14.7M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$7.59M |
| 5 |
Sio Capital Management
New York
|
+$7.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$11.5M |
| 2 |
Logos Global Management
San Francisco,
California
|
-$10.2M |
| 3 |
SummitTX Capital
Fort Worth,
Texas
|
-$9.6M |
| 4 |
Boxer Capital Management
San Diego,
California
|
-$7.92M |
| 5 |
Woodline Partners
San Francisco,
California
|
-$2.17M |
QTTB Hedge Fund Activity: Q3 2026 in Review
106 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q3 2026, worth a combined $262M — down 7.3% from $283M a quarter earlier.
Buyers outnumbered sellers: 48 funds opened new QTTB positions and 15 closed out — a net gain of 33 holders — while 24 added to existing stakes and 15 trimmed.
The largest buyer was Bank of America, opening a new position worth an estimated $30.5M. The largest seller was Point72 Asset Management, cutting an estimated $11.5M.
- 106 institutional investors held Q32 Bio (QTTB) as of Q3 2026, up from 73 in Q2 2026.
- Funds reported $262M of Q32 Bio stock for Q3 2026, down 7.3% quarter-over-quarter.
- 48 funds opened new Q32 Bio positions in Q3 2026 and 15 closed out, a net change of +33 holders.
- The largest Q32 Bio buyer in Q3 2026 was Bank of America, an estimated $30.5M added.
- The largest Q32 Bio seller in Q3 2026 was Point72 Asset Management, an estimated $11.5M sold.
Based on aggregated 13F filings for Q3 2026.